Key takeaways
- Lower acquisition costs and flat overhead could let LifeMD keep more of each subscriber's revenue as patient volume grows.
- On its third quarter of 2026 earnings call, held on Nov. 12, 2026, LifeMD (LFMD) announced a strategic shift toward direct pharmacy distribution of branded glucagon-like peptide-1 (GLP-1) weight-loss…
- For long-term investors, the transition to direct relationships with pharmaceutical manufacturers and enterprise partnerships could reduce reliance on marketing and establish durable subscription…
LifeMD partnered with Eli Lilly and Novo Nordisk for direct GLP-1 fulfillment. AT&T collaboration grants 100 million customers free LifeMD virtual healthcare access.
See the latest quote, chart and news for LFMD.
